Cover Image
市場調查報告書

咽喉癌:全球臨床實驗檢討

Laryngeal Cancer Global Clinical Trials Review, H1, 2016

出版商 GlobalData 商品編碼 226850
出版日期 內容資訊 英文 277 Pages
訂單完成後即時交付
價格
Back to Top
咽喉癌:全球臨床實驗檢討 Laryngeal Cancer Global Clinical Trials Review, H1, 2016
出版日期: 2016年05月19日 內容資訊: 英文 277 Pages
簡介

目錄

目錄

  • 表格一覽
  • 圖表一覽
  • 簡介
  • 喉癌
  • 報告指南
  • 臨床實驗 各地區
  • 臨床實驗 各國
  • 對臨床實驗有所貢獻的前幾名國家 - 亞太地區
  • 對臨床實驗有所貢獻的前五國 - 歐洲
  • 對臨床實驗有所貢獻的前幾名國家 - 北美
  • 對臨床實驗有所貢獻的前幾名國家 - 中東及非洲
  • 臨床實驗 ; 金磚四國 各國
  • 臨床實驗 ; G7 各國
  • 臨床實驗 - G7 各國 各臨床實驗狀態
  • 臨床實驗 ; E7 各國
  • 臨床實驗 - E7 各國 各臨床實驗狀態
  • 臨床實驗 各階段
  • 進行中的臨床實驗 各階段
  • 臨床實驗 各臨床實驗狀態
  • 未完成的臨床實驗; 喉癌
  • 每段時期的實驗人數
  • 有力的贊助商
  • 前幾名參與企業 - 喉癌 治療藥物的臨床實驗
  • 潛力治療藥物比較
  • 臨床實驗簡介
  • 臨床實驗概要; 前幾名企業
  • Azienda U.S.L. 4 di Prato
  • 臨床實驗概要; Azienda U.S.L. 4 di Prato
  • MAASTRO CLINIC
  • 臨床實驗概要; MAASTRO CLINIC
  • Pharmacyclics, Inc.
  • 臨床實驗概要; Pharmacyclics, Inc.
  • 臨床實驗概要; 最高級大學 / 研究機關 / 醫院
  • Mount Sinai School of Medicine
  • 臨床實驗概要; Mount Sinai School of Medicine
  • Stanford University
  • 臨床實驗概要; Stanford University
  • Fred Hutchinson Cancer Research Center
  • 臨床實驗概要; Fred Hutchinson Cancer Research Center
  • Groupe Oncologie Radiotherapie Tete et Cou
  • 臨床實驗概要; Groupe Oncologie Radiotherapie Tete et Cou
  • Radboud University
  • 臨床實驗概要; Radboud University
  • Memorial Sloan Kettering Cancer Center
  • 臨床實驗概要; Memorial Sloan Kettering Cancer Center
  • Institut Gustave Roussy
  • 臨床實驗概要; Institut Gustave Roussy
  • Ghent University Hospital
  • 臨床實驗概要; Ghent University Hospital
  • European Organization for Research and Therapeutics of Cancer
  • 臨床實驗概要; European Organization for Research and Therapeutics of Cancer
  • Southwest Oncology Group
  • 臨床實驗概要; Southwest Oncology Group
  • Tehran University of Medical Sciences
  • 臨床實驗概要; Tehran University of Medical Sciences
  • Centre Hospitalier Universitaire de Nimes
  • 臨床實驗概要; Centre Hospitalier Universitaire de Nimes
  • Southern Illinois University
  • 臨床實驗概要; Southern Illinois University
  • The University of Iowa
  • 臨床實驗概要; The University of Iowa
  • University of Leipzig
  • 臨床實驗概要; University of Leipzig
  • Rabin Medical Center
  • 臨床實驗概要; Rabin Medical Center
  • Fox Chase Cancer Center
  • 臨床實驗概要; Fox Chase Cancer Center
  • Shiraz University of Medical Sciences
  • 臨床實驗概要; Shiraz University of Medical Sciences
  • University of Campinas, Brazil
  • 臨床實驗概要; University of Campinas, Brazil
  • Wake Forest University
  • 臨床實驗概要; Wake Forest University
  • 5件重要臨床簡介

附錄

  • 簡稱
  • 定義
  • 調查方法
  • 二級研究
  • 關於GlobalData
  • 諮詢方式
  • 免責聲明
  • 資訊來源

表格一覽

  • 喉癌 全球治療藥物市場, 臨床實驗 各地區
  • 喉癌 全球治療藥物市場, 臨床實驗 各國排名
  • 喉癌 全球治療藥物市場, 進行中的臨床實驗 各國排名
  • 喉癌 治療藥物的臨床實驗, 亞太地區, 前幾名國家
  • 喉癌 治療藥物的臨床實驗, 歐洲, 前五國
  • 喉癌 治療藥物的臨床實驗, 北美, 前幾名國家
  • 喉癌 治療藥物的臨床實驗, 中東及非洲, 前幾名國家
  • 喉癌 治療藥物的臨床實驗, 金磚四國 各國
  • 喉癌 治療藥物的臨床實驗, G7 各國
  • 喉癌 治療藥物市場, G7 各國, 臨床實驗 各臨床實驗狀態
  • 喉癌 治療藥物的臨床實驗, E7 各國
  • 喉癌 治療藥物市場, E7 各國, 臨床實驗 各臨床實驗狀態
  • 喉癌 全球治療藥物市場, 臨床實驗 各階段
  • 喉癌 全球治療藥物市場, 進行中的臨床實驗 各階段
  • 喉癌 全球治療藥物市場, 臨床實驗 各臨床實驗狀態
  • 喉癌 全球治療藥物市場, 終止的臨床實驗
  • 喉癌 全球治療藥物臨床實驗, 平均登錄對象人數趨勢
  • 喉癌 全球治療藥物臨床實驗, 主要的贊助商
  • 喉癌 全球治療藥物臨床實驗, 前幾名企業 各階段
  • 喉癌 全球治療藥物臨床實驗, 臨床實驗 ; 潛力治療藥物
  • 喉癌 全球治療藥物臨床實驗市場, 臨床實驗 ; Azienda U.S.L. 4 di Prato
  • 喉癌 全球治療藥物臨床實驗市場, 臨床實驗 ; MAASTRO CLINIC
  • 喉癌 全球治療藥物臨床實驗市場, 臨床實驗 ; Pharmacyclics, Inc. 
  • 喉癌 全球治療藥物臨床實驗市場, 臨床實驗 ; Mount Sinai School of Medicine
  • 喉癌 全球治療藥物臨床實驗市場, 臨床實驗 ; Stanford University
  • 喉癌 全球治療藥物臨床實驗市場, 臨床實驗 ; Fred Hutchinson Cancer Research Center
  • 喉癌 全球治療藥物臨床實驗市場, 臨床實驗 ; Groupe Oncologie Radiotherapie Tete et Cou
  • 喉癌 全球治療藥物臨床實驗市場, 臨床實驗 ; Radboud University
  • 喉癌 全球治療藥物臨床實驗市場, 臨床實驗 ; Memorial Sloan Kettering Cancer Center
  • 喉癌 全球治療藥物臨床實驗市場, 臨床實驗 ; Institut Gustave Roussy
  • 喉癌 全球治療藥物臨床實驗市場, 臨床實驗 ; Ghent University Hospital
  • 喉癌 全球治療藥物臨床實驗市場, 臨床實驗 ; European Organization for Research and Therapeutics of Cancer
  • 喉癌 全球治療藥物臨床實驗市場, 臨床實驗 ; Southwest Oncology Group
  • 喉癌 全球治療藥物臨床實驗市場, 臨床實驗 ; Tehran University of Medical Sciences
  • 喉癌 全球治療藥物臨床實驗市場, 臨床實驗 ; Centre Hospitalier Universitaire de Nimes
  • 喉癌 全球治療藥物臨床實驗市場, 臨床實驗 ; Southern Illinois University
  • 喉癌 全球治療藥物臨床實驗市場, 臨床實驗 ; The University of Iowa
  • 喉癌 全球治療藥物臨床實驗市場, 臨床實驗 ; University of Leipzig
  • 喉癌 全球治療藥物臨床實驗市場, 臨床實驗 ; Rabin Medical Center
  • 喉癌 全球治療藥物臨床實驗市場, 臨床實驗 ; Fox Chase Cancer Center
  • 喉癌 全球治療藥物臨床實驗市場, 臨床實驗 ; Shiraz University of Medical Sciences
  • 喉癌 全球治療藥物臨床實驗市場, 臨床實驗 ; University of Campinas, Brazil
  • 喉癌 全球治療藥物臨床實驗市場, 臨床實驗 ; Wake Forest University

圖表一覽

  • 喉癌 全球治療藥物市場, 臨床實驗 各地區 (%)
  • 喉癌 全球治療藥物市場, 臨床實驗 各國排名
  • 喉癌 全球治療藥物市場, 進行中的臨床實驗 各國排名
  • 喉癌 治療藥物的臨床實驗, 亞太地區, 前幾名國家 (%)
  • 喉癌 治療藥物的臨床實驗, 歐洲, 前五國 (%)
  • 喉癌 治療藥物的臨床實驗, 中東及非洲, 前幾名國家 (%)
  • 喉癌 治療藥物的臨床實驗, 金磚四國 各國 (%)
  • 喉癌 治療藥物的臨床實驗, G7 各國 (%)
  • 喉癌 治療藥物市場, G7 各國, 臨床實驗 各臨床實驗狀態
  • 喉癌 治療藥物的臨床實驗, E7 各國 (%)
  • 喉癌 全球治療藥物市場, 臨床實驗 各階段 (%)
  • 喉癌 全球治療藥物市場, 進行中的臨床實驗 各階段
  • 喉癌 全球治療藥物市場, 臨床實驗 各臨床實驗狀態
  • 喉癌 全球治療藥物臨床實驗, 平均登錄對象人數趨勢
  • 喉癌 全球治療藥物臨床實驗, 主要的贊助商
  • 喉癌 全球治療藥物臨床實驗, 前幾名企業 各階段
  • 喉癌 全球治療藥物臨床實驗, 臨床實驗 ; 潛力治療藥物
  • GlobalData 調查方法

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDHC3395CTIDB

GlobalData's clinical trial report, "Laryngeal Cancer Global Clinical Trials Review, H1, 2016" provides an overview of Laryngeal Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Laryngeal Cancer. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Five Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Five Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Laryngeal Cancer to Oncology Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Laryngeal Cancer to Oncology Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Laryngeal Cancer Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profile Snapshots
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Laryngeal Cancer Therapeutics, Global, Clinical Trials by Region, 2016*
  • Laryngeal Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016*
  • Laryngeal Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016*
  • Laryngeal Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2016*
  • Laryngeal Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2016*
  • Laryngeal Cancer Therapeutics Clinical Trials, North America, Top Countries, 2016*
  • Laryngeal Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2016*
  • Laryngeal Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2016*
  • Proportion of Laryngeal Cancer to Oncology Clinical Trials, G7 Countries (%), 2016*
  • Laryngeal Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2016*
  • Laryngeal Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016*
  • Proportion of Laryngeal Cancer to Oncology Clinical Trials, E7 Countries (%), 2016*
  • Laryngeal Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2016*
  • Laryngeal Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016*
  • Laryngeal Cancer Therapeutics, Global, Clinical Trials by Phase, 2016*
  • Laryngeal Cancer Therapeutics, Global, Clinical Trials In Progress by Phase 2016*
  • Laryngeal Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2016*
  • Laryngeal Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2016*
  • Laryngeal Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015
  • Laryngeal Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016*
  • Laryngeal Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2016*
  • Laryngeal Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016*
  • Laryngeal Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016*

List of Figures

  • Laryngeal Cancer Therapeutics, Global, Clinical Trials by Region (%), 2016*
  • Laryngeal Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016*
  • Laryngeal Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016*
  • Laryngeal Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2016*
  • Laryngeal Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016*
  • Laryngeal Cancer Therapeutics Clinical Trials, North America, Top Countries (%), 2016*
  • Laryngeal Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2016*
  • Laryngeal Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2016*
  • Proportion of Laryngeal Cancer to Oncology Clinical Trials, G7 Countries (%), 2016*
  • Laryngeal Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2016*
  • Laryngeal Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016*
  • Proportion of Laryngeal Cancer to Oncology Clinical Trials, E7 Countries (%), 2016*
  • Laryngeal Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2016*
  • Laryngeal Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016*
  • Laryngeal Cancer Therapeutics, Global, Clinical Trials by Phase (%), 2016*
  • Laryngeal Cancer Therapeutics, Global, Clinical Trials In Progress by Phase, 2016*
  • Laryngeal Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2016*
  • Laryngeal Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2016*
  • Laryngeal Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015
  • Laryngeal Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016*
  • Laryngeal Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2016*
  • Laryngeal Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016*
  • Laryngeal Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016*
  • GlobalData Methodology
Back to Top